SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-134490
Filing Date
2021-11-04
Accepted
2021-11-04 17:07:36
Documents
46
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ckpt-20210930x10q.htm   iXBRL 10-Q 1356142
2 EXHIBIT 31.1 ckpt-20210930xex31d1.htm EX-31.1 11488
3 EXHIBIT 31.2 ckpt-20210930xex31d2.htm EX-31.2 10293
4 EXHIBIT 32.1 ckpt-20210930xex32d1.htm EX-32.1 5759
5 EXHIBIT 32.2 ckpt-20210930xex32d2.htm EX-32.2 5389
  Complete submission text file 0001104659-21-134490.txt   4501403

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ckpt-20210930.xsd EX-101.SCH 34830
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ckpt-20210930_cal.xml EX-101.CAL 22239
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ckpt-20210930_def.xml EX-101.DEF 150428
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ckpt-20210930_lab.xml EX-101.LAB 244759
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ckpt-20210930_pre.xml EX-101.PRE 218776
11 EXTRACTED XBRL INSTANCE DOCUMENT ckpt-20210930x10q_htm.xml XML 645817
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38128 | Film No.: 211381055
SIC: 2834 Pharmaceutical Preparations